JPH11279061A - Antipruritic solution - Google Patents
Antipruritic solutionInfo
- Publication number
- JPH11279061A JPH11279061A JP10083986A JP8398698A JPH11279061A JP H11279061 A JPH11279061 A JP H11279061A JP 10083986 A JP10083986 A JP 10083986A JP 8398698 A JP8398698 A JP 8398698A JP H11279061 A JPH11279061 A JP H11279061A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- menthol
- antipruritic
- preparation
- chlorpheniramine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001139 anti-pruritic effect Effects 0.000 title claims abstract description 17
- 239000003908 antipruritic agent Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 38
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940041616 menthol Drugs 0.000 claims abstract description 12
- 229960003291 chlorphenamine Drugs 0.000 claims abstract description 10
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 16
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims description 5
- 229940046978 chlorpheniramine maleate Drugs 0.000 claims description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 10
- 239000008213 purified water Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000002826 coolant Substances 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は鎮痒液剤に関し、さ
らに詳しくは清涼感が向上し、かつ、皮膚刺激を抑えた
鎮痒液剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antipruritic solution, and more particularly, to an antipruritic solution having improved refreshing feeling and reduced skin irritation.
【0002】[0002]
【従来の技術】従来、虫さされなどのかゆみ止めとして
種々の外用製剤が販売されており、通常、鎮痒成分とし
てジフェンヒドラミン、塩酸イソチベンジルなどの抗ヒ
スタミン薬が配合される。それらの製剤の剤型は、液剤
またはゲル剤が一般的であるが、ゲル剤は塗布後のべた
付き感などがあり、使用感の点では液剤の方が好まし
い。また、そのような製剤は夏場に使うことが多いた
め、使用感を良くし、製品性の向上を図ることから使用
時の清涼感を増加させる必要がある。2. Description of the Related Art Conventionally, various external preparations have been marketed as an antipruritic for insect bites and the like. Usually, antihistamines such as diphenhydramine and isothibenzyl hydrochloride are compounded as antipruritic components. The dosage form of these preparations is generally a liquid preparation or a gel preparation, but the gel preparation has a sticky feeling after application, and the liquid preparation is more preferable in terms of usability. In addition, since such preparations are often used in the summer, it is necessary to increase the refreshing sensation at the time of use in order to improve the feeling of use and improve the product properties.
【0003】一般的に外用剤に用いる清涼化剤としては
メントール、カンフル、サリチル酸メチルなどが知られ
ている。それらの清涼化剤は塗布数分以降に持続する清
涼感に大きく関与している。[0003] Generally, menthol, camphor, methyl salicylate and the like are known as cooling agents used for external preparations. These cooling agents are significantly involved in the refreshing sensation that persists after several minutes of application.
【0004】[0004]
【発明が解決しようとする課題】本発明者らは鎮痒液剤
の清涼感向上のために、種々の清涼化剤について検討を
行ったところ、カンフルは塗布したときの熱感が生じる
ため使用感が好ましくなく、サリチル酸メチルは増量す
ると特異なにおいのため製品性の低下を招くことがわか
った。したがって、清涼感向上のために用いる清涼化剤
としてはメントールが最も好ましい。DISCLOSURE OF THE INVENTION The present inventors have studied various refreshing agents to improve the refreshing feeling of an antipruritic solution. Undesirably, it was found that increasing the amount of methyl salicylate causes a reduction in product properties due to a specific odor. Therefore, menthol is most preferred as a cooling agent used for improving the refreshing feeling.
【0005】従来は清涼感を得るために配合するメント
ールの量が少量であっても、他の清涼化剤をさらに配合
することにより清涼感を補っていた。しかし、刺激感や
灼熱感のため製剤全体としての使用感を損なうことがあ
った。Conventionally, even if the amount of menthol to be added to obtain a refreshing feeling is small, the refreshing feeling has been supplemented by further adding another cooling agent. However, the feeling of use as the whole preparation may be impaired due to the irritating feeling and burning sensation.
【0006】一方、液剤の場合は清涼感向上のためにメ
ントールの配合量を増加すると、塗布した際に皮膚刺激
が生じることがあることを見出した。On the other hand, it has been found that in the case of a liquid preparation, if the amount of menthol is increased in order to improve the refreshing feeling, skin irritation may occur when applied.
【0007】本発明の目的は清涼感を向上し、かつ、皮
膚刺激が低減した鎮痒液剤を得ることにある。An object of the present invention is to provide an antipruritic solution which improves the refreshing sensation and reduces skin irritation.
【0008】[0008]
【課題を解決するための手段】本発明者らは種々検討し
た結果、高濃度のメントールを配合した製剤に、鎮痒成
分としてクロルフェニラミンを配合し液剤とすると、清
涼感に優れ、かつ、低刺激の鎮痒液剤となることを見出
し本発明を完成した。As a result of various studies, the present inventors have found that, when a liquid preparation is prepared by adding chlorpheniramine as an antipruritic component to a preparation containing a high concentration of menthol, a refreshing feeling and a low refreshing feeling can be obtained. The present invention was found to be a stimulant antipruritic solution and completed the present invention.
【0009】すなわち本発明はA)製剤全体の3W/V%
以上のメントール、B)クロルフェニラミンまたはその
塩、および(C)製剤全体の20〜45W/V%の水、か
らなる鎮痒液剤である。That is, the present invention relates to A) 3 W / V% of the whole preparation
An antipruritic solution comprising the above menthol, B) chlorpheniramine or a salt thereof, and (C) water of 20 to 45 W / V% of the whole preparation.
【0010】[0010]
【発明の実施の形態】本発明においてメントールとはdl
-メントールまたはl-メントールのことである。本発明
においてはメントールの配合量は製剤全体の3W/V%以
上配合する必要がある。3W/V%未満の配合量であると
清涼感が十分でないからである。DESCRIPTION OF THE PREFERRED EMBODIMENTS In the present invention, menthol is dl
-Menthol or l-menthol. In the present invention, the amount of menthol must be 3 W / V% or more of the whole preparation. If the amount is less than 3 W / V%, the refreshing feeling is not sufficient.
【0011】本発明でクロルフェニラミンの塩とは、医
薬品として許容される酸との塩であり、最も好ましいも
のとしてマレイン酸クロルフェニラミンがあげられる。In the present invention, the salt of chlorpheniramine is a salt with a pharmaceutically acceptable acid, most preferably chlorpheniramine maleate.
【0012】本発明でのクロルフェニラミンまたはその
塩の配合量は、クロルフェニラミンの量に換算して製剤
全体の0.01〜2W/V%が好ましい。The amount of chlorpheniramine or a salt thereof in the present invention is preferably 0.01 to 2 W / V% of the whole preparation in terms of the amount of chlorpheniramine.
【0013】本発明の液剤は、塗布時に液状の剤型、例
えば液剤、ローション剤、乳液剤、エアゾール剤などで
ある必要がある。ゲル、軟膏などのゼリー状の剤型は、
塗布後にべたつくなど使用感の点で好ましくないからで
ある。The liquid preparation of the present invention must be in a liquid form at the time of application, for example, a liquid preparation, a lotion preparation, an emulsion preparation, an aerosol preparation and the like. Jelly-like dosage forms such as gels and ointments
This is because it is not preferable in terms of usability such as stickiness after coating.
【0014】本発明の液剤は、清涼感の点で製剤中に水
を配合する必要がある。そのときの水の配合量は20〜
45W/V%が好ましい。20W/V%未満であると、清涼感
が十分得られず、45W/V%を越えて配合すると、配合
成分の溶解度が低下することから製剤を製造しにくくな
るからである。In the liquid preparation of the present invention, it is necessary to mix water in the preparation from the viewpoint of refreshing feeling. The amount of water at that time is 20-
45 W / V% is preferred. If the content is less than 20 W / V%, a refreshing feeling cannot be sufficiently obtained, and if the content is more than 45 W / V%, the solubility of the blended components is reduced, so that it becomes difficult to produce a preparation.
【0015】本発明の液剤は、液剤に一般的に使用され
る成分などを配合して通常の製法により製造することが
できる。The liquid preparation of the present invention can be produced by a usual production method by blending components generally used in the liquid preparation.
【0016】[0016]
【発明の効果】本発明により清涼感が向上し、かつ、刺
激が生じない鎮痒液剤を得ることが可能になったので、
医薬品などに使用することができる。EFFECT OF THE INVENTION The present invention makes it possible to obtain an antipruritic solution which improves the refreshing sensation and does not cause irritation.
It can be used for medicines and the like.
【0017】[0017]
【実施例】以下、実施例および試験例により本発明をさ
らに詳細に説明する。The present invention will be described in more detail with reference to the following Examples and Test Examples.
【0018】実施例1Embodiment 1
【0019】[0019]
【表1】 マレイン酸クロルフェニラミン 0.3g dl-メントール 3.5g 精製水 40g エタノール 全100ml マレイン酸クロルフェニラミンおよびdl-メントールを
エタノール約40mlに溶解した。精製水を加え、エタノ
ールで全量を100mlにして液剤を得た。Table 1 Chlorpheniramine maleate 0.3 g dl-menthol 3.5 g Purified water 40 g ethanol Total 100 ml Chlorpheniramine maleate and dl-menthol were dissolved in about 40 ml of ethanol. Purified water was added, and the total volume was adjusted to 100 ml with ethanol to obtain a liquid preparation.
【0020】比較例1 実施例1のマレイン酸クロルフェニラミンを塩酸ジフェ
ンヒドラミン2g(実施例1と同程度の鎮痒効果)に変
更した処方で、実施例1と同様にして比較用液剤を得
た。Comparative Example 1 A liquid formulation for comparison was obtained in the same manner as in Example 1 except that chlorpheniramine maleate of Example 1 was changed to 2 g of diphenhydramine hydrochloride (an antipruritic effect similar to that of Example 1).
【0021】試験例1 実施例1および比較例1で得られた液剤について、Drai
z法(「新しい皮膚の生理と安全性」清至書院、176
頁)により皮膚一次刺激性の評価をした。被験動物とし
て日本白色兎を用い各液剤ごとに3匹で試験した。各被
験動物ごとに一次刺激性インデックス(P.I.I.)を求
め、3匹の平均を各液剤のP.I.I.値とした。Test Example 1 The liquid preparations obtained in Example 1 and Comparative Example 1
z method ("New skin physiology and safety", Seiji Shoin, 176
P.) Was evaluated for primary skin irritation. Japanese white rabbits were used as test animals, and the test was performed with three of each liquid. The primary irritability index (PII) was determined for each test animal, and the average of the three animals was used as the PII value of each solution.
【0022】その結果、実施例1の液剤は0.5であ
り、比較例1の液剤は3.0であった。As a result, the liquid preparation of Example 1 was 0.5, and the liquid preparation of Comparative Example 1 was 3.0.
Claims (2)
ル、B)クロルフェニラミンまたはその塩、および
(C)製剤全体の20〜45W/V%の水、からなる鎮痒
液剤。1. An antipruritic liquid comprising: A) menthol of 3 W / V% or more of the whole preparation; B) chlorpheniramine or a salt thereof; and (C) 20 to 45 W / V% of water of the whole preparation.
レイン酸クロルフェニラミン、および製剤全体の20〜
45W/V%の水、からなる鎮痒液剤。(2) menthol, chlorpheniramine maleate of 3 W / V% or more of the whole preparation, and 20 to 30% of the whole preparation;
An antipruritic solution comprising 45 W / V% water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10083986A JPH11279061A (en) | 1998-03-30 | 1998-03-30 | Antipruritic solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10083986A JPH11279061A (en) | 1998-03-30 | 1998-03-30 | Antipruritic solution |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11279061A true JPH11279061A (en) | 1999-10-12 |
Family
ID=13817868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10083986A Pending JPH11279061A (en) | 1998-03-30 | 1998-03-30 | Antipruritic solution |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11279061A (en) |
-
1998
- 1998-03-30 JP JP10083986A patent/JPH11279061A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5990100A (en) | Composition and method for treatment of psoriasis | |
JP2003183157A (en) | Ophthalmologic composition | |
NZ197882A (en) | Antiherpetically active lipstick | |
JPH09506865A (en) | New composition | |
JP2000327557A (en) | Emulsified composition | |
JPH0347252B2 (en) | ||
JP2003505419A (en) | Ophthalmic composition containing ketotifen | |
JPH0463852B2 (en) | ||
JP2002212107A (en) | Topical application composition | |
JP3608209B2 (en) | Crotamiton combination external preparation | |
JPS6241645B2 (en) | ||
JP3899267B2 (en) | Use of tosylchloramide to treat skin, mucous membrane, organ or tissue disorders | |
JPS6169721A (en) | Antimycotic composition | |
JP2000198719A (en) | Hair growing agent | |
JP2002114711A (en) | External preparation composition | |
JPH11279061A (en) | Antipruritic solution | |
JP2003055193A (en) | Refrigerant-containing gel-like external preparation | |
JP2003206224A (en) | External composition | |
JP2003171204A (en) | Gel-like insect repellent formulation | |
JPH0137370B2 (en) | ||
JP2675111B2 (en) | Minoxidil gel | |
JP2001163777A (en) | Skin lotion | |
JPH07126159A (en) | Emulsion ointment | |
JPH07126191A (en) | Cream agent | |
JPH05229949A (en) | Salicylic acid-blended preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050304 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050304 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081202 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090331 |